5.07 USD
↘ 0.06 (1.17%)AT CLOSE (03:59 PM EDT)
Atea Pharmaceuticals, Inc. Common Stock
AVIRNASDAQ • USD
5.09
↗ 0.01 (0.30%)
POST MARKET (AS OF 05:19 PM EDT)
Post Market
AS OF 05:19 PM EDT
5.09
↗ 0.01 (0.30%)
Market: OPEN
Atea Pharmaceuticals, Inc. Common Stock (AVIR) trades at $5.09 per share. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, AVIR appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 6, 2026.
Open?$5.16
High?$5.19
Low?$4.98
Prev. Close?$5.13
Volume?229.4K
Avg. Volume?271.7K
VWAP?$5.09
Rel. Volume?0.84x
Bid / Ask
Bid?$4.26 × 100
Ask?$6.62 × 100
Spread?$2.36
Midpoint?$5.44
Valuation & Ratios
Market Cap?411.5M
Shares Out?80.2M
Float?61.1M
Float %?76.2%
P/E Ratio?N/A
P/B Ratio?2.02
EPS?-$2.06
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Employees
55
Market Cap
411.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-10-30
Address
225 FRANKLIN STREET
BOSTON, MA 02110
Phone: (857) 284-8891
BOSTON, MA 02110
Phone: (857) 284-8891
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?86
Momentum?50
Short Sent.?28
Piotroski F-Score?0/9Weak
Altman Z-Score?3.58Safe
Confidence?48%Low
Short InterestVery High
Short % of Float?12.49%High
Short Interest?7.6M
Days to Cover?27.3
Free Float61.1M
Avg Daily Volume279.5K
Settlement Date2026-09-15
Financial Health
Current Ratio?8.13Strong
Quick Ratio?8.13Strong
Cash Ratio?2.72Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.02CHEAP▾
Peers100
S&P74
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-81.0%WEAK▾
S&P3
ROA?-71.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-152073000
Enterprise Value?$334.9M
Fundamentals ratios updated end of day